tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jenscare Scientific Schedules Board Meeting to Review Interim Results

Story Highlights
Jenscare Scientific Schedules Board Meeting to Review Interim Results

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Jenscare Scientific Co. Ltd. Class H ( (HK:9877) ) is now available.

Jenscare Scientific Co., Ltd. has announced a forthcoming board meeting scheduled for August 27, 2025, to discuss and approve the interim financial results for the first half of the year ending June 30, 2025. The meeting will also consider the recommendation for an interim dividend payment, which could have significant implications for shareholders and stakeholders, reflecting the company’s financial health and strategic direction.

More about Jenscare Scientific Co. Ltd. Class H

Jenscare Scientific Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating with a focus on scientific and technological advancements. The company, along with its subsidiaries, is involved in the development and provision of innovative scientific solutions.

Average Trading Volume: 1,115,413

Technical Sentiment Signal: Buy

Current Market Cap: HK$5.12B

Learn more about 9877 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1